Announcement under Regulation 30 (LODR)-Change in Management
Filed with BSE · ISIN INE380K01017 · · 5 pages · English
Summary by 6ix AI
The meeting included the re-appointment of several directors and discussed the company's financial statements for the previous year. The filing also provides details about the voting process and the attendance of directors and auditors during the meeting. The document serves to inform shareholders and comply with regulatory requirements under SEBI regulations.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Subject : Proceedings/Outcome of the 39th Annual General Meeting (AGM) of the Company held on September 30, 2026 We refer to our letter dated September 08, 2026, informing you that the 39th Annual General Meeting (‘AGM’) of the Members of the Company is scheduled through Video Conference (VC) / Other Audio-Visual Means (OAVM) on September 30, 2026. Bhavish Vijayvargiya Company Secretary & Complian
Story so far
Earlier from Vivo Bio Tech
- Shareholder Meeting / Postal Ballot-Outcome of AGM
- Vivo Bio Tech Ltd. Press Release Sep 25 2026
- Closure of Trading Window
- Web Link Intimation
- Vivo Bio Tech Ltd. Press Release Sep 09 2026
Later from Vivo Bio Tech
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- Vivo Bio Tech Ltd. Press Release Sep 30 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Follow Vivo Bio Tech into a list and get an email when it puts out news.
Follow Vivo Bio Tech